Commentary|Videos|July 10, 2025
Removing Financial Barriers to Boost Trial Diversity
Author(s)Andy Studna, Senior Editor
In this video interview, Heather Horville, solutions consultant at Greenphire, explains how upfront reimbursement, travel stipends, and flexible support services can empower more patients—especially those from underserved communities—to confidently enroll and stay in clinical trials.
Advertisement
In a recent video interview with Applied Clinical Trials, Heather Horville, solutions consultant, Greenphire, discussed the challenges of retention and trial timelines due to increasing financial and logistical burdens on patients. Horville highlighted strategies to address these issues, such as early planning, patient advocacy, and site selection based on local needs. For complex trials, engagement through diary entries and stipends, and human interaction via concierge services will be critical. Future improvements will emphasize a comprehensive patient journey, incorporating services like travel prepayment to enhance trial success.
ACT: What roles do reimbursement, stipends, and other participant support measures play in improving trial diversity, and how should these be operationalized at the site level?
Horville: There's a lot less resources and communities of lower socioeconomic status, not just financially, but we think of, do they have family support nearby? Do they have caregivers able to help out? Do they have access to transportation? Sites must always be in the loop, and aware of what's going on with our patients. They're on the front lines. If we're going to employ a strategy, we need to make sure that it's streamlined. We need to make sure that it's easy for sites, and we want to provide patients an optimal experience, so having flexible options based on where the sites are around the world and what the patient prefers is really important, but we do really want to make sure that we are implementing that strategy to reimburse patients, to provide stipends, to prepay for travel, and really help ensure that they can enroll confidently and that they can be retained.
Newsletter
Stay current in clinical research with Applied Clinical Trials, providing expert insights, regulatory updates, and practical strategies for successful clinical trial design and execution.
Advertisement
Related Articles
- Latest NIMBLE Study Results Highlight Progress in gMG Research
September 12th 2025
- ACT Brief Episode 8: Expert Insights on the Future of Obesity Drug Trials
September 11th 2025
- How ClinOps Teams Should Evaluate GenAI Tools in Trial Discovery
September 11th 2025
- How Recent Policy Changes Could Impact Clinical Research
September 10th 2025
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
Phase III BRUIN CLL-313 Trial Finds Jaypirca Extends Progression-Free Survival in Treatment-Naïve CLL/SLL
2
FDA Fast Tracks Sanofi’s Intravitreal Gene Therapy for Neovascular Age-Related Macular Degeneration
3
ACT Brief Episode 8: Expert Insights on the Future of Obesity Drug Trials
4
How ClinOps Teams Should Evaluate GenAI Tools in Trial Discovery
5